Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.06 | - |
NAV | ₹20.20 | - |
Fund Started | 06 Oct 2020 | - |
Fund Size | ₹162.74 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.06
-
NAV
₹20.20
-
Fund Started
06 Oct 2020
-
Fund Size
₹162.74 Cr
-
Exit Load
-
-
Returns
1 Year | 2.35% | - |
3 Year | 17.36% | - |
5 Year | 15.05% | - |
1 Year
2.35%
-
3 Year
17.36%
-
5 Year
15.05%
-
Holding Analysis
Equity | 99.79% | - |
Cash | 0.10% | - |
Equity
99.79%
-
Cash
0.10%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.89% |
Max Healthcare Institute Ltd. | 6.17% |
Cipla Ltd. | 6.05% |
Apollo Hospitals Enterprise Ltd. | 5.31% |
Eli Lilly And Co | 5.25% |
Dr. Reddy's Laboratories Ltd. | 5.09% |
Divi's Laboratories Ltd. | 4.84% |
Johnson & Johnson Ltd. | 3.80% |
AbbVie Inc | 3.49% |
Fortis Healthcare Ltd. | 3.39% |
-
Fund Manager
Name | Bhavesh Jain | - |
Start Date | 12 Aug 2025 | - |
Name
Bhavesh Jain
-
Start Date
12 Aug 2025
-
About Fund
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | - |
Launch Date | 06 Oct 2020 | - |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
-
Launch Date
06 Oct 2020
-